SORBS1, a member of the PPAR pathway, can suppress tumour metastasis and promote chemotherapy sensitivity in cancer,46, 47 but has also been reported to correlate with prostate cancer recurrence.48 This evidence concerns the gene SORBS1 and prostate carcinoma.